Search clinical trials for: Programmed Cell Death 1 Ligand 1 (PDL1, PD-L1)
Total 93420 results
-
Greg Durm, MDMerck Sharp & Dohme LLC; Big Ten Cancer Research ConsortiumCompleted
-
Jason J. Luke, MDRecruitingMelanoma | Cervical Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | NSCLC | Advanced Solid Tumors | Cholangiocarcinoma | Bladder Cancer | Renal Cancer | Anal Cancer | Merkel Cell Carcinoma | HNSCCUnited States
-
Second Affiliated Hospital of Soochow UniversitySciClone PharmaceuticalsRecruitingAdvanced Solid Tumor | Refractory TumorChina
-
Peking UniversityNot yet recruitingGastroesophageal Junction Cancer | Chemoradiotherapy | PD-1
-
Changhai HospitalNational Natural Science Foundation of ChinaCompleted
-
Merck Sharp & Dohme LLCTerminated
-
IO BiotechMerck Sharp & Dohme LLCCompletedNSCLCUnited Kingdom, Germany, Netherlands, Spain
-
Shanghai Zhongshan HospitalRecruiting
-
Tongji HospitalWuhan University; Sun Yat-sen University; Wuhan Union Hospital, ChinaSuspendedNon Small Cell Lung CancerChina
-
Beijing Friendship HospitalNot yet recruiting
-
Shanghai Chest HospitalRecruitingNon Small Cell Lung CancerChina
-
First Affiliated Hospital of Harbin Medical UniversityNot yet recruitingSmall-cell Lung Cancer
-
Novartis PharmaceuticalsActive, not recruitingAdvanced Solid Tumors | Triple Negative Breast Cancer | Chordoma and Alveolar Soft Part SarcomaUnited States, Taiwan, Spain, Canada, Singapore, Italy, Japan, Israel, France
-
Sun Yat-sen UniversityRecruitingPD-1 Inhibitor | G-CSFChina
-
Novartis PharmaceuticalsCompletedMelanoma | Triple Negative Breast Cancer | Anaplastic Thyroid Cancer | Other Solid Tumors | Non-small Sell Lung Cancer (NSCLC)United States, Italy, Spain, Hungary, Taiwan, Germany, Netherlands, France, Norway, Poland, Thailand, Lebanon, Turkey, Canada
-
Incyte CorporationWithdrawn
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Jiangsu HengRui Medicine Co., Ltd.CompletedAdvanced Solid TumorsChina
-
Agenus Inc.CompletedAdvanced Solid Cancers | Advanced Solid Cancers Refractory to PD-1United States
-
NYU Langone HealthEMD SeronoCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI); Incyte CorporationRecruitingPancreatic Cancer Metastatic | Pancreatic Cancer Non-resectableUnited States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruiting
-
Hunan Cancer HospitalXiangya Hospital of Central South University; Innovent Biologics (Suzhou) Co...UnknownSmall Cell Lung Carcinoma | Small-cell Lung Cancer | Small Cell Lung Cancer Extensive Stage | Small Cell Lung Cancer RecurrentChina
-
Bristol-Myers SquibbWithdrawnStage III or IV Melanoma
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; Marker Therapeutics, Inc.Completed
-
AstraZenecaCompleted
-
National Institute for Tuberculosis and Lung Diseases...SuspendedInterstitial Lung Disease | Lung Neoplasm MalignantPoland
-
Qilu Hospital of Shandong UniversityWithdrawn
-
Merck Sharp & Dohme LLCEuropean Organisation for Research and Treatment of Cancer - EORTC; ETOPActive, not recruiting
-
Case Comprehensive Cancer CenterCompletedMetastatic Renal Cell CancerUnited States
-
Shanghai Pulmonary Hospital, Shanghai, ChinaRecruiting
-
Hoffmann-La RocheRecruitingPD-L1-selected Solid TumorsKorea, Republic of, United States, Spain, Taiwan, Turkey, Greece, Canada, Croatia, Serbia, Mexico, Cyprus, Georgia
-
Cancer Research UKHeptares Therapeutics LimitedRecruitingSarcoma | Neoplasms | Kidney Neoplasms | Uterine Cervical Neoplasms | Stomach Neoplasms | Head and Neck Neoplasms | Lung Neoplasms | Urinary Bladder Neoplasms | Colorectal Neoplasms | Pancreatic Neoplasms | Esophageal Neoplasms | Mesothelioma, Malignant | Prostatic Neoplasms, Castration-Resistant | PheochromocytomasUnited Kingdom
-
Bristol-Myers SquibbWithdrawnMultiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin's Lymphoma | Chronic Myelogenous Leukemia
-
University of LeipzigRecruitingHepatocellular CarcinomaGermany
-
Merck Sharp & Dohme LLCRecruitingMelanomaSpain, Poland, United States, Australia, France, Israel, Italy, South Africa, Switzerland, Chile, Greece, Colombia, Hungary, Argentina
-
AkesoAkeso Pharmaceuticals, Inc.CompletedMelanoma | Advanced Solid TumorsChina
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingGlioblastoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Advanced Solid Tumors | Triple Negative Breast Cancer | Biliary Tract CancersUnited States, Argentina, Australia, Canada, Chile, Colombia, France, Germany, Israel, Italy, Korea, Republic of, Russian Federation, Spain, Switzerland, Taiwan, Thailand, United Kingdom
-
Hunan Province Tumor HospitalCompleted
-
BeiGeneRecruitingNon-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Spain, Malaysia, Italy, Canada, Thailand, Georgia, Brazil, Korea, Republic of, Singapore, Moldova, Republic of, Romania
-
Yale UniversityTerminatedAsymptomatic MyelomaUnited States
-
University of Colorado, DenverRecruiting
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Stand Up To Cancer; CellSight Technologies, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC)United States
-
Sun Yat-sen UniversityRecruitingColorectal Cancer Stage IV | Mismatch Repair-deficient (dMMR) | Microsatellite Instability-high (MSI-H)China
-
Fuzhou General HospitalUnknownRenal Cell CarcinomaChina
-
Maxinovel Pty., Ltd.Recruiting
-
Maxinovel Pty., Ltd.Recruiting
-
Sohag UniversityNot yet recruitingNasopharyngeal and Hypopharyngeal CarcinomaEgypt
-
Fondazione Ricerca TraslazionaleUnknownTo Define an Easy and Feasible Panel Which May be Routinely Applied to Select Patients for Immunotherapy Avoiding More Complex and Expensive Methods